Events and webinars

MIPIM 2024

Meet us at MIPIM!

Antitrust for emerging companies – what you need to know

Antitrust isn't just for big companies! Emerging companies may view antitrust as an issue primarily for large companies or as a lower priority given their size. However, emerging companies...

U.S. Market access strategy at the clinical stage for all companies considering a launch: A three-part series

The complexity of the U.S. market access landscape means that proving safety and efficacy is no longer a guarantee of commercial success. This three-part series will provide you with the...

Beyond the Business Pitch at JP Morgan: Key Issues for Emerging Companies and Investors in 2022

Finding the right investor who shares your passion for the mission and the sense of urgency to meet the objectives is key. JP Morgan and Biotech Showcase are bringing industry leaders...

Loading data